The diagnostic process for patients with suspected autoimmune diseases is often long and uncertain, characterized by vague symptoms, overlapping clinical presentations and limitations in traditional serological testing. This complexity can delay accurate diagnosis and treatment, leading to disease progression and diminished quality of life. This webinar will explore how advanced serological testing methods are helping clinicians navigate this complexity by enhancing diagnostic precision for autoimmune diseases such as lupus and rheumatoid arthritis.
These tests provide a comprehensive serological profile by combining cell-bound complement activation products (CB-CAPs), high-quality systemic lupus erythematosus (SLE)-specific biomarkers and an interpretive algorithm to support more confident and earlier diagnosis. This enables physicians to act decisively at a critical juncture in the patient’s journey. Through real-world case studies, this session will highlight how diagnostic clarity from enhanced testing approaches has informed provider decision-making, enabled appropriate therapeutic initiation and ultimately led to improved patient outcomes.
Tailored for rheumatologists and healthcare professionals involved in autoimmune diseases, this webinar offers practical, evidence-based insights into the role of innovative diagnostics in daily clinical practice. Attendees will gain a deeper understanding of how leveraging advanced diagnostic tools can enhance decision-making and improve the lives of patients affected by these complex and chronic conditions.
Register now to discover how advanced serological testing is revolutionizing the diagnosis and treatment of autoimmune diseases.
Speakers
Dr. Alfred Kim, MD, PhD, Associate Professor, Medicine, Washington University School of Medicine
Dr. Alfred Kim is an Associate Professor of Medicine at Washington University School of Medicine, where he directs the Lupus Center, which he founded in 2013. He also directs the Biobanking and Phenotyping Core within the NIH/NIAMS P30-funded Rheumatic Diseases Research Resource-based Center, is a Faculty Scholar at the Institute of Public Health and serves as the Associate Program Director for the Rheumatology Fellowship Program, all at Washington University. Additionally, he is the Chief Medical Officer at Kypha, Inc., an innate immune diagnostics company.
Message Presenter
Dr. James Mossell, MD, Director of Rheumatology, Tift Regional Medical Center
More info coming soon..
Message PresenterWho Should Attend?
This webinar will appeal to:
- Rheumatologists/Rheumatology Nurse Practitioners/Rheumatology Physician Assistants
- Generalists
- Immunologists
- Healthcare professionals
- Clinical Researchers at hospitals and Specialist Consultants in Rheumatology and Clinical Immunology
- Program Leads/Heads of Rheumatology at pharma and biotech companies
What You Will Learn
Attendees will:
- Understand how advanced autoimmune testing supports diagnostic clarity in early or ambiguous clinical presentations
- Review case-based evidence of how serological test results can inform long-term clinical decisions
- Learn how providers are using comprehensive serologic profiles to increase confidence in diagnosis and inform individualized patient care
- Gain confidence in using innovative diagnostic tools along with routine autoimmune workups for better care
Xtalks Partner
Exagen Inc.
Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company. We aid patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. Our relentless pursuit for laboratory excellence has enabled us to develop next-generation autoimmune testing to help empower physicians and improve patients’ lives.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account